Moonlake Immunotherapeutics (MLTX) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Moonlake Immunotherapeutics  (NASDAQ: MLTX)

Moonlake Immunotherapeutics Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MLTX Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) - 68.81 % 54.17 % 38.77 %
Gross Margin (Q2 TTM) - 69.19 % 55.83 % 38.1 %
Gross Profit Margin 5 Yr. Avg. - 62.89 % 52.78 % 32.58 %
EBITDA Margin (Q2 MRQ) - 24.91 % 21.71 % 22.17 %
EBITDA Margin (Q2 TTM) - 28.72 % 23.59 % 20.85 %
EBITDA Margin 5 Yr. Avg. - 50.51 % 34.71 % 23.59 %
Operating Margin (Q2 MRQ) - 17.3 % 16.59 % 16.03 %
Operating Margin (Q2 TTM) - 20.31 % 17.93 % 16.33 %
Operating Margin 5 Yr. Avg. - 15.4 % 14.73 % 16.68 %
Pre-Tax Profit Margin (Q2 MRQ) - 13.66 % 10.94 % 13.94 %
Pre-Tax Profit Margin (Q2 TTM) - 16.68 % 12.84 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 13.31 % 10.65 % 12.23 %
Net Margin (Q2 MRQ) - 10.08 % 8.14 % 11.41 %
Net Margin (Q2 TTM) - 13.07 % 9.96 % 10.76 %
Net Margin 5 Yr. Avg. - 6.08 % 6.13 % 9.62 %



Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q2 MRQ) - -0.01 % 0.21 % 1.39 %
Free Cash Flow Margin (Q2 TTM) - 17.25 % 14.06 % 9.37 %
Free Cash Flow Margin 5 Yr. Avg. - 20.92 % 15.77 % 13.9 %
Net Cash Flow Margin (Q2 MRQ) - 0.02 % -0.02 % 0.13 %
Net Cash Flow Margin (Q2 TTM) - -0.76 % 0.09 % 1.79 %
Net Cash Flow Margin 5 Yr. Avg. - 4.19 % 3.09 % 5.71 %
Effective Tax Rate (Q2 MRQ)